Position in LLY
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$4,947,777,626
-$741,193,012 QoQ
Shares Held
5,379,364
+1.6% QoQ
Ownership
0.571%
of shares outstanding
% of Portfolio
1.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Legal & General Group Plc holds $25,087,571,930 across 12 Drug Manufacturers - General names. LLY ranks #2 (19.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
25,849,978 | $5,098,132,659 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
5,379,364 | $4,947,777,626 | |
| 3 | JNJ |
Johnson & Johnson
|
19,347,862 | $4,729,391,386 | |
| 4 | ABBV |
AbbVie Inc.
|
12,159,427 | $2,644,553,777 | |
| 5 | MRK |
Merck & Co., Inc.
|
19,538,545 | $2,350,291,577 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
10,464,889 | $1,458,491,578 | |
| 7 | AMGN |
Amgen Inc
|
3,870,863 | $1,361,963,146 | |
| 8 | PFE |
Pfizer Inc
|
43,505,563 | $1,221,636,207 |
All Filings in LLY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,947,777,626 | 5,379,364 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $5,688,970,638 | 5,293,641 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $4,107,991,237 | 5,383,999 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,076,384,534 | 5,229,285 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $4,547,087,147 | 5,505,548 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $4,311,654,740 | 5,585,045 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $5,017,648,764 | 5,663,644 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $6,442,489,422 | 7,115,785 | Shares | Defined | 2024-08-14 | |
| 2023-12-31 | $4,158,200,943 | 7,133,399 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $3,182,390,508 | 5,924,805 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,864,182,794 | 6,107,260 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,029,944,630 | 5,910,968 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,122,054,553 | 5,800,499 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,918,469,177 | 5,933,104 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,023,295,062 | 6,240,308 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $1,803,073,721 | 6,296,308 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,642,004,428 | 5,944,553 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,388,704,074 | 6,010,405 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,347,495,622 | 5,870,929 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $1,053,595,301 | 5,639,628 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $972,996,384 | 5,762,831 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $842,699,321 | 5,693,145 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $955,415,793 | 5,819,319 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $809,465,185 | 5,835,245 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||